Nature Reports Stem Cells
Publisher: Springer Nature · ISSN 1754-8705 · 25 articles
-
State of the stem cell
An overview of the not-so-distant past, and an outlook for the not-so-distant future
-
RepSox hits a home run
Small molecule can replace Sox2 , c-Myc in reprogramming
-
Finding real iPS cells early
Live-cell imaging techniques move toward a definitive assay for pluripotency
- Ihor Lemischka: stem cells meet systems biology
-
FDA green lights stem cell clinical trial for Lou Gehrig's disease
Neural stem cells to be injected in patients' spines
- NIH waits for scientists to submit ES lines for funding eligibility
- Prostate tumours from a surprising source
-
The rocky road to regulation
Why unproven, risky medical practices elude legal restrictions
-
(Stem cell) banking crisis
Stem cell banking must expand to keep up with demand, say researchers
- Davor Solter: non-retiring with stem cells in Singapore
-
Stem-cell drug fails crucial trials
Experimental treatment does not halt fatal complication of bone-marrow transplant.
- A bank in England for stem cells
-
International Society for Stem Cell Research reading list
A compliation of papers covered in talks at the 7^th annual meeting
-
What does Nanog do?
In embryos and induced pluripotent stem cells, Nanog sets the ground state of pluripotency
-
Induced pluripotent stem cells, down to one factor
Human neural stem cells reprogrammed with only OCT4
-
Stem cells delay disease onset in mice with neurodegenerative disease
Transplanted cells from biotech company detoxify poisoned brains, at least for awhile
-
iPS cells used to probe rare neurodegenerative disease
Study investigates what goes wrong in familial dysautonomia and assesses potential treatments
-
Please do not eat the stem cells
Cancers copy normal stem cells to avoid phagocytosis
-
Melissa Carpenter: making stem cells for many, safely
Barriers must be overcome to move cell therapies from the laboratory to the clinic
- Zinc fingers splice genes in human pluripotent stem cells
-
p53 prevents pluripotency
The guardian of the genome also blocks reprogramming
-
Building bones from stem cells
An analysis finds tissue-specific stem cells make chemically and functionally different bone than embryonic ones
-
Irving Weissman: creating a standard for stem cell therapies and culturing the unorthodox
The new president of the ISSCR says that to move forward, the field must think outside the box
-
Human embryonic stem cell research stuck on two early lines
Field shows legacy of funding policies, early-mover advantage
-
Cancer stem cells resemble healthy stem cells, resist chemotherapy
Recent papers show how tumour-initiating cells work, and why they're hard to treat